Sorafenib and entecavir: The dioscuri of treatment for advanced hepatocellular carcinoma?

被引：4
|
作者：
D'Angelo, Salvatore [1 ]
Secondulfo, Mario [1 ]
De Cristofano, Raffaele [1 ]
Sorrentino, Paolo [1 ]
机构：
[1] SG Moscati Hosp, Liver Unit, I-83100 Avellino, Italy
来源：
WORLD JOURNAL OF GASTROENTEROLOGY | 2013年 / 19卷 / 14期
关键词：
Entecavir; Hepatocellular carcinoma; Hepatitis B virus; Liver function; Sorafenib; HEPATITIS-B-VIRUS; CIRRHOSIS; EFFICACY; INFECTION; THERAPY; CANCER;
D O I：
10.3748/wjg.v19.i14.2141
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
Hepatitis B virus (HBV) is responsible for 50%-80% of cases of hepatocellular carcinoma (HCC) worldwide. Entecavir (ET) is a potent inhibitor of chronic HBV-DNA polymerase, inhibiting both the priming and elongation steps of viral DNA replication. Sorafenib (SO) has proven efficacy in prolonging survival in patients with advanced HCC. In this frontier report we discuss a possible way to optimize treatment outcomes in patients with HBV and HCC by treatment with ET and SO, on the basis of our practice and published evidence from the literature. (C) 2013 Baishideng. All rights reserved.
引用
收藏
页码：2141 / 2143
页数：3
相关论文
共 50 条
  • [41] Sorafenib for the Treatment of Unresectable Hepatocellular Carcinoma
    Kane, Robert C.
    Farrell, Ann T.
    Madabushi, Rajanikanth
    Booth, Brian
    Chattopadhyay, Somesh
    Sridhara, Rajeshwari
    Justice, Robert
    Pazdur, Richard
    ONCOLOGIST, 2009, 14 (01): : 95 - 100
  • [42] Sorafenib for the treatment of unresectable hepatocellular carcinoma
    Furuse, Junji
    BIOLOGICS-TARGETS & THERAPY, 2008, 2 (04): : 779 - 788
  • [43] Combined sorafenib and yttrium-90 radioembolization for the treatment of advanced hepatocellular carcinoma
    Salman, A.
    Simoneau, E.
    Hassanain, M.
    Chaudhury, P.
    Boucher, L. M.
    Valenti, D.
    Cabrera, T.
    Nudo, C.
    Metrakos, P.
    CURRENT ONCOLOGY, 2016, 23 (05) : E472 - E480
  • [44] A LONG-LASTING RESPONSE TO SORAFENIB TREATMENT IN AN ADVANCED HEPATOCELLULAR CARCINOMA PATIENT
    Di Lorenzo, G.
    Imbimbo, M.
    Leopardo, D.
    Marciano, R.
    Federico, P.
    Buonerba, C.
    Salvatore, B.
    Marinelli, A.
    Palmieri, G.
    INTERNATIONAL JOURNAL OF IMMUNOPATHOLOGY AND PHARMACOLOGY, 2010, 23 (03) : 951 - 954
  • [45] Sunitinib in Patients with Advanced Hepatocellular Carcinoma after Progression under Sorafenib Treatment
    Woerns, Marcus Alexander
    Schuchmann, Marcus
    Dueber, Christoph
    Otto, Gerd
    Galle, Peter Robert
    Weinmann, Arndt
    ONCOLOGY, 2010, 79 (1-2) : 85 - 92
  • [46] Early Experience of Combination Treatment of Sorafenib and Radiotherapy in Advanced Hepatocellular Carcinoma Patients
    Cha, J.
    Seong, J.
    Han, K.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2010, 78 (03): : S306 - S307
  • [47] Safety and efficacy of sorafenib in the treatment of advanced hepatocellular carcinoma: a single center experience
    Rodrigo Imedio, Esteban
    Diaz Beveridge, Roberto
    Aparicio Urtasun, Jorge
    Bruixola Campos, Gema
    Lorente Estelles, David
    Fonfria Esparcia, Maria
    Caballero Daroqui, Javier
    Segura Huerta, Angel
    Gimenez Ortiz, Alejandra
    Montalar Salcedo, Joaquin
    MEDICAL ONCOLOGY, 2014, 31 (05) : 1 - 6
  • [48] PHARMACOECONOMIC EVALUATION OF SORAFENIB AS FIRST-LINE TREATMENT FOR ADVANCED HEPATOCELLULAR CARCINOMA
    Naumovska, Z.
    Nestorovska, Kapedanovska A.
    Grozdanova, A.
    Suturkova, L.
    Dimovski, A.
    Sterjev, Z.
    VALUE IN HEALTH, 2017, 20 (09) : A736 - A736
  • [49] Sorafenib Dose Ramp-up Scheme for the Treatment of Advanced Hepatocellular Carcinoma
    Kim, J. E.
    Ryoo, B. Y.
    Ryu, M. H.
    Chang, H. M.
    Suh, D. J.
    Lee, H. C.
    Lim, Y. S.
    Klm, K. M.
    Kang, Y. K.
    EUROPEAN JOURNAL OF CANCER, 2011, 47 : S466 - S466
  • [50] Sorafenib in the treatment of advanced Hepatocellular Carcinoma (HCC) -: Experiences beyond the sharp trial
    Woerns, M.-A.
    Schulze-Bergkamen, W.
    Schuchmann, M.
    Otto, G.
    Galle, P. R.
    Weinmann, A.
    ONKOLOGIE, 2008, 31 : 80 - 80
12345